BeiGene Ltd. Capital Reinvestment Ratio

Latest as of March 2025: 2.64x

BeiGene Ltd. capital reinvestment ratio. BeiGene Ltd. (49B) has a Capital Reinvestment Ratio of 2.64x as of March 2025, meaning it reinvests 3% of its operating cash flow (€44.08 Million) in capital expenditures (€116.41 Million). See cash generation quality of BeiGene Ltd. to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.64x
Capex / Operating Cash Flow

Operating Cash Flow

€44.08 Million
EUR

Capital Expenditures

€116.41 Million
EUR

Data as of

Mar 2025
Most recent filing

Capital Reinvestment Ratio of BeiGene Ltd. (2017–2017)

Capital reinvestment ratio of BeiGene Ltd. from 2017 to 2017. This chart tracks BeiGene Ltd.'s Capital Reinvestment Ratio across 1 annual periods. See how financially flexible is BeiGene Ltd. to measure the company's free cash flow as a share of total liabilities.

BeiGene Ltd. Capital Reinvestment Ratio by Year (2017–2017)

BeiGene Ltd. capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see 49B cash flow metrics.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2017 3.64x €12.75 Million €46.37 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow